Günther Bernhardt

Günther Bernhardt

Auto-generated profile, based on publicly available information

Günther Bernhardt

Institute of Pharmacy, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstrasse 31, D-93053 Regensburg, Germany

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in Biochemical Pharmacology
Verified
Journal Article
Closed access
SBSilke Beermann
Silke Beermann
GBGuenther Bernhardt
Guenther Bernhardt
RSRoland Seifert
Roland Seifert
ABArmin Buschauer
Armin Buschauer
DNDetlef Neumann
Detlef Neumann

19 November 2019 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Open access
MKMax Keller
Max Keller
SMShahani A. Mahuroof
Shahani A. Mahuroof
VYVivyanne Hong Yee
Vivyanne Hong Yee
JCJessica Carpenter
Jessica Carpenter
LSLisa Schindler
Lisa Schindler
NHNicholas D. Holliday
Nicholas D. Holliday
Fluorescence-labeled receptor ligands have emerged as valuable molecular tools, being indispensable for studying receptor–ligand interactions by fluorescence-based techniques such as high-content imaging, fluorescence microscopy, and fluorescence polarization. Through application of a new labeling strategy for peptides, a series of fluorescent neurotensin(8–13) derivatives was synthesized by attaching red-emitting fluorophores (indolinium- and pyridinium-type cyanine dyes) to carbamoylated arginine residues in neurotensin(8–13) analogues, yielding fluorescent probes with high NTS1R affinity (pKi values: 8.15–9.12) and potency (pEC50 values (Ca2+ mobilization): 8.23–9.43). Selected fluorescent ligands were investigated by flow cytometry and high-content imaging (saturation binding, kinetic studies, and competition binding) as well as by confocal microscopy using intact CHO-hNTS1R cells. The study demonstrates the applicability of the fluorescent probes as molecular tools to obtain, for example, information about the localization of receptors in cells and to determine binding affinities of nonlabeled ligands.

10 May 2019 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
LSLisa Schindler
Lisa Schindler
GBGünther Bernhardt
Günther Bernhardt
MKMax Keller
Max Keller

18 May 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
EBEdith Bartole
Edith Bartole
LGLukas Grätz
Lukas Grätz
TLTimo Littmann
Timo Littmann
DWDavid Wifling
David Wifling
USUlla Seibel
Ulla Seibel
GBGünther Bernhardt
Günther Bernhardt

6 August 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LGLukas Grätz
Lukas Grätz
KTKatharina Tropmann
Katharina Tropmann
MBMerlin Bresinsky
Merlin Bresinsky
CMChristoph Müller
Christoph Müller
GBGünther Bernhardt
Günther Bernhardt
SPSteffen Pockes
Steffen Pockes
Fluorescence/luminescence-based techniques play an increasingly important role in the development of test systems for the characterization of future drug candidates, especially in terms of receptor binding in the field of G protein-coupled receptors (GPCRs). In this article, we present the establishment of a homogeneous live cell-based BRET binding assay for the histamine H2 receptor with different fluorescently labeled squaramide-type compounds synthesized in the course of this study. Py-1-labeled ligand 8 (UR-KAT478) was found to be most suitable in BRET saturation binding experiments with respect to receptor affinity (pKd = 7.35) and signal intensity. Real-time kinetic experiments showed a full association of 8 within approximately 30 min and a slow dissociation of the ligand from the receptor. Investigation of reference compounds in BRET-based competition binding with 8 yielded pKi values in agreement with radioligand binding data. This study shows that the BRET binding assay is a versatile test system for the characterization of putative new ligands at the histamine H2 receptor and represents a valuable fluorescence-based alternative to canonical binding assays.

Verified
Journal Article
Open access
PDF file
Carina HöringCarina Höring
Carina Höring
USUlla Seibel-Ehlert
Ulla Seibel-Ehlert
KTKatharina Tropmann
Katharina Tropmann
LGLukas Grätz
Lukas Grätz
DMDenise Mönnich
Denise Mönnich
ASAndrea Strasser
Andrea Strasser
In drug discovery, assays with proximal readout are of great importance to study target-specific effects of potential drug candidates. In the field of G protein-coupled receptors (GPCRs), the determination of GPCR-G protein interactions and G protein activation by means of radiolabeled GTP analogs ([35S]GTPγS, [γ-32P]GTP) has widely been used for this purpose. Since we were repeatedly faced with insufficient quality of radiolabeled nucleotides, there was a requirement to implement a novel proximal functional assay for the routine characterization of putative histamine receptor ligands. We applied the split-NanoLuc to the four histamine receptor subtypes (H1R, H2R, H3R, H4R) and recently engineered minimal G (mini-G) proteins. Using this method, the functional response upon receptor activation was monitored in real-time and the four mini-G sensors were evaluated by investigating selected standard (inverse) agonists and antagonists. All potencies and efficacies of the studied ligands were in concordance with literature data. Further, we demonstrated a significant positive correlation of the signal amplitude and the mini-G protein expression level in the case of the H2R, but not for the H1R or the H3R. The pEC50 values of histamine obtained under different mini-G expression levels were consistent. Moreover, we obtained excellent dynamic ranges (Z’ factor) and the signal spans were improved for all receptor subtypes in comparison to the previously performed [35S]GTPγS binding assay.